SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vista Pharmaceuticals trades in fine fettle on BSE

25 Apr 2017 Evaluate

Vista Pharmaceuticals is currently trading at Rs. 46.10, up by 0.95 points or 2.10% from its previous closing of Rs. 45.15 on the BSE.

The scrip opened at Rs. 46.95 and has touched a high and low of Rs. 47.20 and Rs. 44.55 respectively. So far 54848 shares were traded on the counter.

The BSE group 'XT' stock of face value Rs. 2 has touched a 52 week high of Rs. 47.95 on 17-Apr-2017 and a 52 week low of Rs. 12.56 on 07-Jun-2016.

Last one week high and low of the scrip stood at Rs. 47.30 and Rs. 42.75 respectively. The current market cap of the company is Rs. 123.55 crore.

The promoters holding in the company stood at 31.19%, while Institutions and Non-Institutions held 0.05% and 68.75% respectively.

Vista Pharmaceuticals has paid GDUFA (Generic Drug User Fee Amendments of 2012) Facility fees payable by the company to US Food & Drug Administration (USFDA). GDUFA is a law designed to speed access to safe and effective generic drugs to the public, and reduce costs to industry.

Vista Pharmaceuticals is engaged in manufacturing and selling of pharmaceutical, medical and veterinary preparations. The company also sells the products to its related companies, which are engaged in the manufacture of formulations.

Vista Pharma Share Price

7.88 0.69 (9.60%)
22-Apr-2026 11:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.00
Dr. Reddys Lab 1219.85
Cipla 1230.15
Zydus Lifesciences 931.80
Lupin 2314.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×